OSTX

OSTX

OS Therapies Incorporated Common Stock

$1.840+-0.000 (-0.000%)

リアルタイム価格

価格チャート

Loading Chart...

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$1.840

高値

$1.840

安値

$1.840

出来高

0.08M

企業ファンダメンタルズ

取引統計

関連ニュース

PR Newswire

OS Therapies Partners with EVERSANA for the U.S. Commercialization of OST-HER2 in Recurrent, Fully Resected, Pediatric Lung Metastatic Osteosarcoma

OS Therapies Inc. (NYSE-A: OSTX) ("OS Therapies" or "the Company"), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology...

もっと見る
OS Therapies Partners with EVERSANA for the U.S. Commercialization of OST-HER2 in Recurrent, Fully Resected, Pediatric Lung Metastatic Osteosarcoma
Analyst Upgrades

D. Boral Capital Maintains Buy on OS Therapies, Maintains $20 Price Target

D. Boral Capital analyst Jason Kolbert maintains OS Therapies with a Buy and maintains $20 price target.

もっと見る
D. Boral Capital Maintains Buy on OS Therapies, Maintains $20 Price Target
BusinessWire

OS Therapies Submits Request for Regenerative Medicine Advanced Therapy (RMAT) Designation to U.S. FDA for OST-HER2 in the Prevention of Metastases in Recurrent, Fully-Resected, Lung Metastatic Pediatric Osteosarcoma

If awarded, OST-HER2 would become the first listeria investigational medicinal product to be awarded the RMAT designation RMAT designation reduces BLA application review time and permits augmented interactions with

もっと見る
OS Therapies Submits Request for Regenerative Medicine Advanced Therapy (RMAT) Designation to U.S. FDA for OST-HER2 in the Prevention of Metastases in Recurrent, Fully-Resected, Lung Metastatic Pediatric Osteosarcoma